Dyadic International (DYAI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for June 20, 2025, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by June 19, 2025.
Voting matters and shareholder proposals
Election of one Class III director, Mark A. Emalfarb, for a term ending in 2028.
Ratification of Crowe LLP as independent registered public accounting firm for the year ending December 31, 2025.
Advisory vote on compensation of Named Executive Officers.
Advisory vote on the frequency of the advisory vote on executive compensation.
Other business may be transacted as may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director election and auditor ratification.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Dyadic International
- Commercial product launches and partnerships are driving revenue growth, with more expected by 2027.DYAI
Life Sciences Virtual Investor Forum12 Mar 2026 - Rapid commercialization in non-therapeutic markets targets profitability by 2026.DYAI
Small-Cap Virtual Conference3 Feb 2026 - New partnerships and strong cash position support growth despite lower Q2 revenue.DYAI
Q2 20241 Feb 2026 - Q3 2024 revenue up 5x, net loss narrowed, and cash reserves reached $10M.DYAI
Q3 202414 Jan 2026 - Revenue growth, narrowed losses, and major grants set up multiple product launches in 2025.DYAI
Q4 202419 Dec 2025 - Registering 840,384 shares for resale from convertible notes; no proceeds to the company.DYAI
Registration Filing16 Dec 2025 - Shifted to commercial focus with first bulk sales, global expansion, and strong liquidity.DYAI
Q3 202515 Dec 2025 - Multiple animal-free protein launches and partnerships set the stage for rapid commercial growth.DYAI
IAccess Alpha Virtual MicroCap Conference9 Dec 2025 - Shareholders will vote on director election, auditor ratification, and executive pay, all backed by the Board.DYAI
Proxy Filing2 Dec 2025